Patents by Inventor Stuart Neville Farrow

Stuart Neville Farrow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL LIGAND
    Publication number: 20150197565
    Abstract: The invention provides an isolated protein which is a member of the TNF ligand superfamily and comprises: i) a polypeptide having the amino acid sequence of FIG. 1; or ii) a variant of the polypeptide of i).
    Type: Application
    Filed: July 17, 2014
    Publication date: July 16, 2015
    Applicant: Glaxo Group Limited
    Inventors: Stuart Neville FARROW, Allard Kaptein, Jeremy David Alistair Kitson, Alison J. Winder
  • Method for inhibiting binding to B-cell receptor
    Patent number: 8784814
    Abstract: The invention provides an isolated protein which is a member of the TNF ligand superfamily and comprises: i) a polypeptide having the amino acid sequence of figure (1); or ii) a variant of the polypeptide of i).
    Type: Grant
    Filed: June 28, 2012
    Date of Patent: July 22, 2014
    Assignee: Glaxo Group Limited
    Inventors: Stuart Neville Farrow, Allard Kaptein, Jeremy David Alistair Kitson, Alison J. Winder
  • METHOD FOR INHIBITING BINDING TO B-CELL RECEPTOR
    Publication number: 20140056900
    Abstract: The invention provides an isolated protein which is a member of the TNF ligand superfamily and comprises: i) a polypeptide having the amino acid sequence of figure (1); or ii) a variant of the polypeptide of i).
    Type: Application
    Filed: June 28, 2012
    Publication date: February 27, 2014
    Applicant: Glaxo Group Limited
    Inventors: Stuart Neville Farrow, Allard Kaptein, Jeremy David Alisdair Kitson, Alison Janet Winder
  • Method for inhibiting binding to B-cell receptor
    Patent number: 8216576
    Abstract: The invention provides an isolated protein which is a member of the TNF ligand superfamily and comprising: i) a polypeptide having the amino acid sequence of FIG. 1; or ii) a variant of the polypeptide of i).
    Type: Grant
    Filed: May 8, 2007
    Date of Patent: July 10, 2012
    Assignee: Glaxo Group Limited
    Inventors: Stuart Neville Farrow, Allard Kaptein, Jeremy David Alistair Kitson, Alison J. Winder
  • Member of the TNF Ligand Family
    Publication number: 20090098129
    Abstract: The invention provides an isolated protein which is a member of the TNF ligand superfamily and comprising: i) a polypeptide having the amino acid sequence of figure (1); or ii) a variant of the polypeptide of i).
    Type: Application
    Filed: November 26, 2008
    Publication date: April 16, 2009
    Applicant: SMITHKLINE BEECHAM CORPORATION
    Inventors: Stuart Neville Farrow, Allard Kaptein, Jeremy David Alisdair Kitson, Alison Janet Winder
  • Member of the TNF ligand family
    Patent number: 7399593
    Abstract: The invention provides an isolated protein which is a member of the TNF ligand superfamily and comprising: i) a polypeptide having the amino acid sequence of FIG. (1) or ii) a variant of the polypeptide of i).
    Type: Grant
    Filed: October 5, 1999
    Date of Patent: July 15, 2008
    Assignee: SmithKline Beecham Corporation
    Inventors: Stuart Neville Farrow, Allard Kaptein, Jeremy David Alisdair Kitson, Alison Janet Winder
  • Assay for glucocorticoid receptor signalling pathway
    Publication number: 20030091978
    Abstract: The present invention provides a method of assessing the glucocorticoid receptor signalling pathway modulated by a test compound comprising; (a) providing a cell having a first polynucleotide construct comprising a first reporter gene under the control of a first promoter indicative of a first glucocorticoid receptor signalling pathway; (b) providing a second cell of the same lineage as the cell (a), and comprising a second polynucleotide construct having a second reporter gene under the control of a second promoter indicative of a second glucocorticoid receptor signalling pathway; (c) incubating said first and second cells with a test compound; (d) monitoring for expression of the first and second reporter genes.
    Type: Application
    Filed: November 20, 2002
    Publication date: May 15, 2003
    Inventors: Stuart Neville Farrow, Barbara Maschera, Edward Stephen Rees